Scientific Research and Experimental Development Tax Program for Medical Professionals 

Medical professionals, encompassing specialists, subspecialists, and research scientists involved in research and development (R&D) activities, might qualify for multiple tax benefits under the Scientific Research and Experimental Development (SR&ED) Program. 

The SR&ED Program covers a broad spectrum of activities, including: 

• Laboratory research targeting the discovery of novel knowledge. 
• Exploration for practical applications of new research outcomes or other insights. 
• Conceptualizing and designing potential product or process alternatives, such as prototypes. 
• Tests to discover or assess product or process alternatives, like clinical trials. 
• Adjustments to the formulation or design of a product or process. 
• Designing, constructing, and testing of pre-production prototypes and models. 

The core objective of SR&ED is to further scientific understanding or to achieve technological progress. This necessitates pinpointing a specific uncertainty, which then becomes the foundation for the ensuing research. Projects under SR&ED are executed using a scientific approach, which involves hypothesizing, planning and conducting tests of the hypothesis through experimentation or analysis, and drawing logical conclusions based on the results. 

For instance, a research project by a physician scientist might investigate if a particular treatment method suitable for one patient category (e.g., SABR effective for small kidney cancers) is also applicable for another (e.g., large kidney cancers). Alternatively, it might compare two different techniques to ascertain the superior one, such as in bypass surgeries – comparing cardiopulmonary bypass with off-pump methods. 

When physicians claim SR&ED via their Medical Professional Corporation, they can avail an Investment Tax Credit (ITC) calculated as a percentage of wages plus overhead. The breakdown includes Federal refundable ITCs at 35%, Provincial refundable ITCs at 8%, and Provincial non-refundable ITCs at 3.5%. These ITCs can be used to offset taxes due or can be refunded. 

However, in the past, the CRA has rejected SR&ED claims from physicians, arguing that the SR&ED was not conducted on behalf of Medical Professional Corporations but for hospitals or universities by individual physicians. Additionally, they’ve pointed out that APP/AFP Funding is considered Government Assistance in relation to SR&ED. 

When submitting a SR&ED claim, physicians should be mindful of several factors: 

• Appointment letters specifying research obligations. 
• Publication of results (typically under the name of the doctor or the institution, not the Medical Professional Corporation). 
• Control of R&D by institutions like ethics boards. 
• Access to clinical data (usually through the hospital or university). 

• Intellectual Property ownership. 

Claims under SR&ED necessitate comprehensive documentation of the research undertaken. This encompasses a description of the scientific or technological uncertainties the project aimed to address, a summary of the work done during the year, and a report of the outcomes. Supporting evidence, such as planning documents, experimental designs, project records, photographs, and progress reports, should be retained in case of a review. Corporations must file their SR&ED claims within 18 months following the end of the tax year. 

The charges for preparing a SR&ED claim typically start at $5,000 annually for those who can document their projects using the scientific method. Alternatively, fees can be contingent, ranging from 10-30% of the investment tax credits received.